Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menghui Chen

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cardiovascular Diabetology|September 13, 2017
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitusIra Gantz, Menghui Chen, Shailaja Suryawanshi, et al.
Diabetes Care|August 28, 2015
Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 DiabetesWayne H-H Sheu, Ira Gantz, Menghui Chen, et al.
International Journal of Biological Macromolecules|January 10, 2026
Multifunctional hydrogel based on oxidized sodium alginate and carboxymethyl chitosan delivers minoxidil loaded liposomes for the treatment of androgenetic alopeciaQian Du, XiaoShun Yao, Na Ni, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 5, 2025
Facile Synthesis of Janus Hydrogel for the Treatment of Abdominal Wall Defects by Solvent EvaporationXinyang Chen, Hao Liu, Le Kang, et al.
Carbohydrate Polymers|February 19, 2026
Modular alginate-based hydrogels embedding multilayer nanofibers: A synergistic strategy for hemostasis, antibacterial, and immunomodulatory therapyHao Liu, Yujie Lv, Jiawang Li, et al.
Obesity (Silver Spring, Md.)|April 10, 2010
A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie dietThomas A Wadden, Ken Fujioka, Soren Toubro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2020
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 StudyJonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, et al.
The Lancet. Oncology|April 12, 2021
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyRobert L Coleman, Domenica Lorusso, Christine Gennigens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cardiovascular Diabetology|September 13, 2017
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitusIra Gantz, Menghui Chen, Shailaja Suryawanshi, et al.
Diabetes Care|August 28, 2015
Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 DiabetesWayne H-H Sheu, Ira Gantz, Menghui Chen, et al.
International Journal of Biological Macromolecules|January 10, 2026
Multifunctional hydrogel based on oxidized sodium alginate and carboxymethyl chitosan delivers minoxidil loaded liposomes for the treatment of androgenetic alopeciaQian Du, XiaoShun Yao, Na Ni, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 5, 2025
Facile Synthesis of Janus Hydrogel for the Treatment of Abdominal Wall Defects by Solvent EvaporationXinyang Chen, Hao Liu, Le Kang, et al.
Carbohydrate Polymers|February 19, 2026
Modular alginate-based hydrogels embedding multilayer nanofibers: A synergistic strategy for hemostasis, antibacterial, and immunomodulatory therapyHao Liu, Yujie Lv, Jiawang Li, et al.
Obesity (Silver Spring, Md.)|April 10, 2010
A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie dietThomas A Wadden, Ken Fujioka, Soren Toubro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2020
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 StudyJonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, et al.
The Lancet. Oncology|April 12, 2021
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyRobert L Coleman, Domenica Lorusso, Christine Gennigens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.
Pageof 3